GLP-1 weight-loss drugs significantly reduce heart attacks, strokes, and premature death in a major review of over 90,000 patients across international trials.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
GLP-1 drugs have long-term benefit for heart health, review suggests
90,000+ patients Patients analyzed
Anglia Ruskin University Research institution
Reduced Heart Attacks And Strokes Primary outcome
Meta-Analysis Of International Trials Study type
Significantly Reduced cardiovascular events prevented